Skip to main content

The effect of CSF drain on the optic nerve in idiopathic intracranial hypertension



Elevation of intracranial pressure in idiopathic intracranial hypertension induces an edema of the prelaminar section of the optic nerve (papilledema). Beside the commonly observed optic nerve sheath distention, information on a potential pathology of the retrolaminar section of the optic nerve and the short-term effect of normalization of intracranial pressure on these abnormalities remains scarce.


In this exploratory study 8 patients diagnosed with idiopathic intracranial hypertension underwent a MRI scan (T2 mapping) as well as a diffusion tensor imaging analysis (fractional anisotropy and mean diffusivity). In addition, the clinical presentation of headache and its accompanying symptoms were assessed. Intracranial pressure was then normalized by lumbar puncture and the initial parameters (MRI and clinical features) were re-assessed within 26 h.


After normalization of CSF pressure, the morphometric MRI scans of the optic nerve and optic nerve sheath remained unchanged. In the diffusion tensor imaging, the fractional anisotropy value was reduced suggesting a tissue decompression of the optic nerve after lumbar puncture. In line with these finding, headache and most of the accompanying symptoms also improved or remitted within that short time frame.


The findings support the hypothesis that the elevation of intracranial pressure induces a microstructural compression of the optic nerve impairing axoplasmic flow and thereby causing the prelaminar papilledema. The microstructural compression of the optic nerve as well as the clinical symptoms improve within hours of normalization of intracranial pressure.


Idiopathic intracranial hypertension (IIH) is defined as an elevation of intracranial pressure (ICP) without hydrocephalus or mass lesion and with normal CSF composition [1]. Currently the incidence is estimated at 0.03–2.36 cases per 100,000 of the general population [2,3,4,5,6,7] but it may be assumed that this figure will increase over the next decades as the disorder occurs mainly in obese women and the prevalence of obesity is increasing worldwide from year to year [8, 9]. The clinical picture of IIH is mainly characterized by a rather unspecific and highly variable headache [10] and visual deficits which result mainly from a pressure-induced papilledema [10,11,12,13,14,15,16,17,18,19]. While these symptoms are the main reasons for patients to seek medical advice, other symptoms such as cranial nerve palsies [20,21,22,23,24], olfactory disturbances [25,26,27,28] and cognitive impairment [29,30,31,32] may occur.

Visual alterations are observed in the vast majority of IIH patients [12, 33,34,35] but even so, the detailed mechanisms underlying this functional deficit remain far from being entirely understood. It may seem obvious that the elevation of ICP induces papilledema which in turn causes visual deterioration. However, there are many questions that remain unanswered. For example, it remains unclear if the pressure-induced changes affect exclusively the papilla of the optic nerve (ON) or if other regions along the visual pathway may be affected as well. It may be assumed that beyond the significant abnormalities observed in the papillar region, the ON suffers pressure-induced microstructural alterations in its myelinated retrobulbar segment [36] but it remains unclear if they are the direct consequence of elevated CSF pressure. In this context it is not known if and in which time frame these abnormalities would reverse upon a pressure relief obtained by a lumbar puncture. This aspect is particularly important as it is still unknown how long it takes to develop a papilledema after the increase of ICP. However, given its pathomechanism it is commonly accepted that the development does not occur immediately but requires a certain amount of time to develop upon an elevation of ICP [37, 38]. This delay suggests, that either an elevation of ICP does not immediately lead to an increase in pressure in the CSF space surrounding the ON or that additional mechanisms that go beyond the direct pressure-induced effects complement the functional changes that lead to visual deterioration. This hypothesis is supported by the observations that IIH-associated headache does not correlate to ICP [39, 40], papilledema [41] or any other IIH-related symptom [30] and that pressure relief does not induce a long-term remission of the head pain in the majority of patients [10, 42]. However, even in regard to the assumed short-term benefit of pressure-relief, objective data is limited. This is particularly the case for symptoms that may accompany IIH-related headache, such as nausea, photo- and phonophobia as well as tinnitus. These symptoms seem less significant at first, but in fact they may hamper the early diagnosis of IIH as they can lead the clinician to a misdiagnosis due to the clinical similarity to other headaches such as migraine [10, 11].

Quantitative diffusion tensor imaging (DTI) has been used to investigate various white matter diseases in vivo. It was shown that DTI is sensitive enough to detect axonal degeneration in rat glaucoma model [43] or the wallerian degeneration in acquired blindness [44] or to demonstrate pre- and post-chiasmatic diffusion tensor abnormalities in children with septo-optic dysplasia [45].

The aims of the present study were twofold. First, we sought to investigate if microstructural patterns within the ON may be affected by normalization of CSF pressure using state-of-the-art DTI magnetic resonance (MR) techniques. Secondly, we aimed at dissecting the characteristics of IIH-related headache and its accompanying symptoms as well as to analyze a potential improvement after the reduction of CSF opening pressure.


The study was approved by the local ethics committee of the Charité - Universitätsmedizin Berlin (EA1/005/15). All patients participating in the study provided written informed consent. MRI measurements were performed between Feb. 11, 2015 and Nov. 25, 2015. Patients received two MRI scans during the study, one prior to the lumbar puncture and the second within 26 h (mean 15,54 h) after the lumbar puncture. In several of the cases the lumbar puncture in the study was not the diagnostic puncture, but all patients had no lumbar puncture within the last six months. Beyond the effect on microstructural alterations of the ON, changes of accompanying symptoms such as nausea, photo-, phono-, osmophobia and trigeminoautonomic symptoms were evaluated within that time frame.


Eight patients of Caucasian descent (one male, seven female, mean age: 39,4 ± 3,7 years, BMI: 34,9 ± 1,5 kg/m2) diagnosed before with IIH according to the revised criteria established by Friedman et al. [1] were included in the study. Time of IIH diagnosis was within the last 18 months. Exclusion criteria included any medical conditions, IIH specific medications, surgical procedure that may affect ICP, significant weight loss or lumbar puncture within the last six months. IIH-associated headache was diagnosed according to the diagnostic criteria established by the International Headache Society (ICHD3 beta) [46].

MR imaging (MRI)

MRI was performed on a 1.5 T scanner (Siemens Avanto Magnetom, Erlangen, Germany). In addition to the circularly polarized head coil, a loop surface coil (7 cm diameter) was placed and fixed over the most affected eye according to visual field defects based on the ophthalmological examination. For the evaluation of the ON and the optic nerve sheath (ONS) a coronal turbo spin echo (TSE) sequence was used (repetition time [TR] 6960 msec, echo time [TE] 99 msec, field of view [FOV] 85 × 85 mm2, matrix size of 256 × 256 [in plane resolution 0.332 × 0.332 mm2], slice thickness 2 mm and acquisition time [TA] 7 min 20 s). DTI images were acquired through a single-shot echo planar (EPI) sequence in axial orientation (TR 5448 msec, TE 88 msec, FOV of 192 × 192 mm2, matrix size of 128 × 128 [in plane resolution 1.5 × 1.5 mm2], slice thickness 3 mm, TA 11 min 44 s). The diffusion weighting (b value) was set to 0 and 1000 s mm− 2. Images were acquired with diffusion gradients in 126 directions with a number of acquisitions of 6, comprising 41 slices covering the whole brain. For the assessment of sinus vein stenoses (SVS) and the exclusion of sinus vein thrombosis (SVT) as secondary causes of intracranial hypertension, a 2D time-of-flight (2D TOF) venography (TR 23 msec, TE 6.5 msec, FOV 250 × 250 mm2, matrix size 512 × 512 [in plane resolution 0.488 × 0.488 mm2], slice thickness 2 mm, TA 7 min 40 s) was performed.

Morphometric analysis

To allow a correlation between macroscopic findings and potential microscopic alterations, maximum ONS and ON diameters were measured in the most affected eye on coronal T2w images perpendicular to the ON in the slice with the maximum ONS diameter (Fig. 1a) measured with a MR microscopy surface coil. MRIs were evaluated by a neuroradiologist and a neurologist (E.W., J.H.) in a blinded fashion. To test the interrater agreement, we have calculated Crohnbach’s alpha for the ON diameter and for the FA values.

Fig. 1

a shows an example of a coronal T2w image of the ON and ONS on which ON and ONS diameters where calculated. b shows the coronal T2-mapping. c illustrates the DTI measurements of the ON and depicts an MR-tractography of the ON

Fig. 2

Illustrates the variation in the FA a and MD b values prior and after normalization of CSF pressure through lumbar puncture. The FA value was significantly reduced after normalization of CSF pressure (p = 0.038)


The MRI data has been denoised, corrected for eddy currents and motion and underwent a bias field correction for tractography purposes [47,48,49]. Probabilistic tractography has been performed with the iFOD2 algorithm and by using a seeding and an inclusion spherical region of interest (ROI) at the anterior and posterior positions of the optic nerves [50]. The iFOD2 is a probabilistic algorithm that takes Constrained Spherical Deconvolution (CSD)-estimated fiber orientation distribution (FOD) fields as input. Tracking parameters were set to default with a FOD amplitude cutoff value of 0.05, a streamline minimum length of 5 x voxelsize and a maximum streamline length of 100 x voxelsize.

The depicted image shows 5000 streamlines delineating a patients left and right optic nerves (Fig. 1c).

Fig. 3

Illustrates the changes in ON a and ONS b diameters as well as in T2 values c before and after normalization of CSF pressure. The normalization of CSF pressure did not induce a significant change in any of the three parameters (ON p = 0.130, ONS p = 0.798, T2 p = 0.310)

DTI analysis

DTI data were corrected for eddy current distortion and motion and underwent a bias field correction for tractography purposes [47,48,49]. DTI data were converted from DICOM into NIFTI format using the DICOM to NIFTI format converter dcm2nii (Dicom office toolkit DCMTK,, Oldenburg, Germany). Voxelwise statistical analyses of fractional anisotropy (FA) and mean diffusivity (MD) data were performed using FSL 4.1.8 (FMRIB Software Library, Oxford, UK) [48, 51, 52]. The b0 data were used for brain segmentation using BET (Brain Extraction) [53]. For the segmentation of white and grey matter an automatic segmentation tool (FAST) was used. FA and MD values were calculated by reconstruction of diffusion tensors using FDT (FMRIB’s Diffusion Toolbox) and DTIFIT. Subjects’ FA and MD data were adjusted into an 1x1x1 mm standard space using tract-based spatial statistics (TBSS) [54] with FNIRT (FMRIB’s nonlinear registration tool), which uses a b-spline representation of the registration warp field [55]. For ROI analysis of the optic pathway, optic nerve and optic tract were outlined manually on MPRAGE and transferred to coregistered FA and MD images using Amira 5.3.2 (Visage Imaging Inc., San Diego, CA, USA) [56] (Fig. 1c).

Fig. 4

Depicts the correlations between the difference in FA value and CSF pressure a as well as between the difference of FA values and headache intensity b before and after normalization of CSF pressure. In both cases correlations were not significant (p > 0.05)

T2 analysis

T2 mapping (TR 3100 ms, TE 13,8 ms - 165,6 ms with twelve TEs: 13,8 ms, 27,6 ms, 41,4 ms, 55,2 ms, 69 ms, 82,2 ms, 96,6 ms, 110,4 ms, 124,2 ms, 138 ms, 151,8 ms, 165,6 ms). T2 maps were online reconstructed by using a voxelwise, monoexponential nonnegative least-squares fit analysis (MapIt; Siemens, Erlangen, Germany) with a voxel size of 1.9 × 1.0 × 3 mm3. A ROI was manually delineated around the optic nerve on the T2 maps (Fig. 1b).

Statistical analysis

Statistical analysis was performed using XLSTAT Version 2016.5 (Addinsoft SARL, New York, NY, USA). Normality of the data was calculated using the Shapiro-Wilk test. For the comparison of group means, the Mann-Whitney U-Test was used and data were expressed as median with 5th and 95th percentiles. Statistical significance was assumed at p < 0.05. To estimate the strength of the parameters Pearson’s correlation coefficient and correlation matrices were calculated. Crohnbach’s alpha was used to test for interrater variability.


Morphometric analysis

The morphometric analysis revealed that CSF pressure reduction through lumbar puncture does not affect median ON and ONS diameters of IIH patients within the investigated time frame (ON p = 0.130, ONS p = 0.798) (Table 1, Fig. 1). Crohnbach’s alpha for the ON diameter was α = 0.72 which is accurate according to the small patient number.

Table 1 Summarizes the changes that normalization of CSF pressure induced on several morphometric and DTI measurements

DTI analysis

Compared to the baseline measurement, FA values of the optic nerve were significantly reduced after lumbar puncture (p = 0.038) (Fig 2). In contrast, analysis of the MD values of the optic nerve remained unaffected by lumbar puncture (p = 0.382) (Table 1). Crohnbach’s alpha for the FA values was α = 0.48 which is acceptable according to the small patient number.

T2 analysis

The comparison of the T2 value of the ON before and after lumbar puncture revealed no significant difference (p = 0.310) (Table 1, Fig. 3).

Clinical assessment

The influence on clinical parameters was assessed in the same time frame. At the initial assessment seven out of eight patients (87,5%) presented with headache. Of those patients reporting headache, mean pain intensity, as assessed on a verbal analog scale ranging from zero to ten, was 2,94 ± 1,02. As outlined in Table 2, the majority of the patients had at least one accompanying symptom typically found in migraine, such as nausea, photo-, phono- and osmophobia, and slightly over a third of the patients had trigeminoautonomic symptoms such as lacrimation or rhinorrhea. With the exception of photophobia, which remitted in half of the patients after lumbar puncture, all the other accompanying symptoms including the trigeminoautonomic symptoms remitted completely within the observed time frame. The detailed description of accompanying symptoms as well as their development after lumbar puncture are listed in Table 2.

Table 2 Summarizes the characteristics of the study population as well as the characteristics of IIH-related headache and its accompanying features prior and after normalization of CSF pressure

Following the initial assessment and the first MRI scan all patients underwent a fluoroscopically guided lumbar puncture (E.W.) and CSF opening pressures were measured in the lateral decubitus position. The mean CSF pressure at baseline was 31,00 ± 2,20 cm CSF and was reduced to 12,19 ± 1,06 cm CSF. In the average 24 ml ± 4.8 ml of CSF were withdrawn. After lumbar puncture a second MRI scan and a reassessment of the clinical findings (headache and accompanying symptoms) was performed within 26 h. Following normalization of intracranial pressure headache severity improved in over 60% and photophobia in 50% of the patients. If nausea, phonophobia, osmophobia and/or trigeminoautonomic symptoms were present at baseline, these symptoms remitted completely in all of the affected patients within the observation period of 26 h (Table 2). In line with these findings, 50% of patients suffered from tinnitus at baseline and in all affected patients, symptoms remitted after lumbar puncture (Table 2).

Correlation of imaging parameters with clinical parameters

The change of the headache intensity before and after lumbar puncture did not correlate with the change in the FA values of the optic nerve (r = − 0.626, p = 0.097) (Fig. 4) or with the change of the T2 values measured of the optic nerve (r = − 0.754; p = 0.084). Furthermore, no correlations were observed between the difference of CSF pressure before and after lumbar puncture with the change of the FA (r = 0.323; p = 0.435) (Fig. 4) and T2 values (r = − 0.314, p = 0.544) of the optic nerve.


In the present study we have shown in IIH patients that a reduction of ICP through a lumbar puncture does not induce a reduction of the ON and ONS diameters within the short time frame of 26 h. Furthermore, the DTI analysis of the ON revealed that the reduction in CSF pressure induced a decrease in the FA value reflecting a reduced restriction of the directionality of molecular diffusion. In contrast MD values remained unaffected after lumbar puncture as were the T2 values, indicating that the dysfunction of the ON is unlikely to involve an edematous process.

Neuroimaging techniques and in particular MRI are an essential component of the diagnostic workup of IIH to exclude secondary causes and to identify typical morphometric alterations commonly observed in IIH [1, 15, 18]. These alterations include the empty sella, a distension of the ONS (perioptic subarachnoid space) and a flattening of the posterior aspect of the optic globe [1, 39, 40]. The time lag between the initiation of the elevation of ICP and the establishment of these structural alterations remains unclear [37]. Perhaps even more important from a clinical perspective is the potential reversibility of these findings after normalization of ICP. However, if some or all of the abnormalities observed in the MRI improve after normalization of intracranial pressure is still debated. While an increasing number of publications report an improvement, in particular of the transverse sinus stenoses [57, 58], structured prospective studies addressing this question remain scarce and in regard to the ON and the ONS such studies, to the best of our knowledge, do not exist at all.

The present study investigated the IIH-related alterations of the ON and the ONS as well as their development after normalization of ICP using a loop surface coil on the orbita allowing the acquisition of high-resolution images of these structures.

The findings of our study indicate that the normalization of ICP does not have a short-term effect on morphological alterations of the ON. In contrast, the alteration of the FA value seen in the DTI suggests that elevated ICP affects microstructural integrity of the ON as the pressure-induced compression of the ON tissue leads to an increase in the directionality of molecular diffusion, a consequence that is reversed within hours of pressure relief. It may be speculated that the compression of the optic nerve as such and its microstructural consequences could add to the functional visual deficit induced by the papilledema, which is induced by a pressure-induced decrease in axoplasmic flow, but the answering of this question was beyond the scope of our study. The fact that we did not observe an alteration in the MD value of the ON supports the current pathophysiological concept that the pressure-induced edema is limited to the prelaminar part of the ON head [37, 59], which is located in front of the lamina cribrosa, and the adjacent retina [37], without affecting the postlaminar myelinated section of the ON [60].

Physiological axoplasmic flow depends on an intraaxonal pressure gradient between the ocular portion (maintained by intraocular pressure) and the extraocular portion (maintained by the pressure of the ON tissue) of the ON. The elevation of intracranial and ONS CSF pressure causes an increase of the retrolaminar tissue pressure that is reflected in the observations we made in the DTI of the ON. The elevated tissue pressure results in an imbalance of the intraaxonal pressure gradient that affects axoplasmic flow leading to an axoplasmic flow stasis in the ON head and a papilledema. Axoplasmic stasis leads to a swelling of the ON head and optic disc swelling that, if untreated, result in retinal hemorrhages and ischemia and finally to optic disc atrophy. This pathomechanism, the slow velocity of the axoplasmic flow and therefore the time needed to create an axoplasmic stasis and edema upon mechanical obstruction as well as the narrow capillary CSF communication in the optic canal explain the delay between the elevation of intracranial pressure and papilledema and why these changes are only observed in chronic but not in acute elevations of intracranial pressure [61].

Until now it remains to be clarified in which time frame the reduction of intracranial pressure reverses these findings. Studies investigating the effect on normalization of intracranial pressure on papilledema and visual disturbances generally investigate the evolution of these abnormalities in longer time frames. For example the NORDIC trial investigating the effect of acetazolamide assessed these parameters after 1 month [62]. To the best of our knowledge no study has investigated prospectively the short-term effect within hours of pressure normalization on the retrolaminar, myelinated section of the optic nerve using MR imaging techniques. However, previous studies on olfaction in IIH suggested, that the improvement and therefore the structural abnormalities, may improve within hours of normalization of ICP [28]. Our study shows that when tissue pressure on the ON is relieved, microstructural abnormalities are reversed but morphometric alterations remain unaffected within 26 h (mean 15:54 h) of normalization of ICP. While this seems obvious at first, it is surprising as the increase in CSF pressure within the ONS appears with a substantial delay compared to the intracranial CSF pressure and one would therefore suspect that upon pressure relief, the distention of the compressed optic nerve would occur much later.

Beyond the effect of normalization of ICP on microstructural alterations of the ON observed in the DTI, most of the patients presented accompanying symptoms commonly seen in migraine such as nausea, photo-, phono- and osmophobia and some had trigeminoautonomic symptoms. With the exception of photophobia, all the other accompanying symptoms remitted completely within the observed time frame. While the prevalences of these accompanying symptoms at initial presentation are similar to those observed by Yri et al. [10, 42], our study shows that most of these symptoms remit within hours of normalization of ICP. Interestingly Yri et al. observed that despite normalization of ICP headache and accompanying symptoms persist (or return) 1 month after pressure normalization [10, 11, 42]. Taken together, the findings suggest that pressure relief induces a short-lasting improvement of headache and accompanying symptoms which is not sustaining in a significant number of patients. The reasons for this rebound despite a normalization of ICP remain speculative but could be explained by the patients’ expectance of an improvement (placebo) as well as through a persistent sensitization of trigeminal neurons. In this case, while initially the elevated pressure may suffice to activate these sensitized neurons, this may not be the case shortly after the sudden fall in intracranial pressure but may return after the activation threshold of trigeminal neurons is adjusted to the new conditions. However, these hypotheses are highly speculative and the clarification of these mechanisms was beyond the scope of our study.


While the described findings are novel to the field, the study has a few but significant limitations that need to be taken into account when interpreting the data. First, the results of this study are based on 8 IIH patients so that they are of an exploratory nature and therefore need to be confirmed by larger studies. In this context the DTI results are only slightly significant given the limited amount of patients in this study. However, considering the exploratory nature of the study, the rather large error margin that affected the significance level and the fact that the decrease in the FA value after lumbar puncture reflects the finding of our previous study showing an increased FA value in IIH patients compared to healthy controls [36], suggest that the results are unlikely to change upon increase of the sample size. Furthermore, small or negative MRI findings in some patients on the second MRI scan could be explained with a faster recovery of intracranial CSF pressure after the lumbar puncture. Therefore, larger studies are clearly needed to confirm these findings.

Secondly, the lack of a control group is another limiting factor. However, as the study required a lumbar puncture and two MRI scans within a short time frame, a healthy control group was not included due to ethical considerations.

Thirdly, from a methodological perspective, the FA values provide a measurement that may be the sum of multiple structures and factors within a voxel. Therefore, FA values have to be interpreted in relation to anatomy, pathology and increase in intra- and extracellular water content. Because of the size differences between the axons and the voxels it is only possible and to observe optic nerve microstructure from a macroscopic point of view with DTI. Furthermore, a single voxel may be composed by fiber populations with different spatial orientation resulting in an average increase in FA, that is not due to changes in axonal structure. Therefore, FA is not always a reliable marker of white matter integrity and FA values have to be interpreted with caution, in particular in relation to clinical data [63, 64].

Fourthly, while papilledema was assessed externally by ophthalmoscopic examination at another campus or by the referring ophthalmologist to establish the diagnosis of IIH, we did not re-assess papilledema after lumbar puncture due to logistical reasons. We therefore had only the confirmation that patients had a papilledema but we did not have information on its extent. Therefore, we could not correlate the alteration of the optic nerve measured by changes of fractional anisotropy in relation to the papilledema. Given that this was intended as an exploratory study this question was beyond its scope. However, considering the pathomechanism of the papilledema induced by an elevation of ICP, it is highly unlikely that the papilledema may improve significantly in such a short time frame despite the differences measured in the optic nerve. In addition, assuming that the majority of patients had only a mild papilledema we would expect that our findings would have been more pronounced with more severe papilledemas or with higher CSF pressures.

Finally, in respect to the clinical outcome parameters, a more objective assessment of headache and its impact on quality of life would have been desirable. However, given the exploratory nature of the study and the focusing on the short-term effects post-LP we did not have a longer follow-up period that would have allowed us to use structured quality of life or disability questionnaires as these are commonly based on longer observational periods. However, in that context we would assume that the clinical improvement we observed post-LP is most likely of a short-lived nature as other groups have convincingly shown that most IIH patients do not have a long-term improvement of their headache even if opening pressure is normalized [65].


The findings of our exploratory study show in a DTI analysis that the microstructural abnormalities, which elevation of ICP induces within the ON, can be reversed within 26 h of normalization of ICP. In contrast, high-resolution MRI revealed that morphometric alterations of the retrolaminar, myelinated section of the ON remain unaffected by ICP normalization. As alterations in the T2 values of the morphometric analysis as well as in the MD values of the DTI analysis were also not observed, we deduce that the affection of the retrolaminar section of the ON does not involve an edematous process. Therefore, the pressure-induced edema appears to be restricted to the prelaminar optic disc and retina.

The study further suggests, that alterations of the ON observed in the MRI as well as some clinical features of the disorder (headache and accompanying symptoms) may improve in the hours following normalization of intracranial pressure. Given the exploratory nature of this study, further studies are needed to confirm these findings.

Key findings

Before the study

  • visual alterations are observed in the vast majority of IIH patients

  • visual deficits result mainly from a pressure-induced papilledema

  • the underlying mechanisms are only partially understood

Study adds

  • no obvious change in optic nerve T2 values after withdrawal of CSF

  • small changes in fractional anisotropy of the optic nerve could be observed after lumbar puncture

  • after withdrawal of CSF a small distention of the ON fibers occur



Body Mass Index


Cerebrospinal fluid


Diffusion tensor imaging


Single-shot echo planar


Fractional anisotropy


Fiber orientation distribution


Field of view


International Classification of Headache Disorders


Intracranial pressure


International Headache Society


Idiopathic intracranial hypertension


Mean diffusivity


Magnetic resonance imaging


Optic nerve


Optic nerve sheath


Region of interest


Sinus vein stenosis


Sinus vein thrombosis


Acquisition time


Echo time


Time of flight


Repetition time


Turbo spin echo


  1. 1.

    Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81(13):1159–1165

    Article  Google Scholar 

  2. 2.

    Durcan FJ, Corbett JJ, Wall M (1988) The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 45(8):875–877

    CAS  Article  Google Scholar 

  3. 3.

    McCluskey G et al (2018) Meta-analysis and systematic review of population-based epidemiological studies in idiopathic intracranial hypertension. Eur J Neurol 25(10):1218–1227

    CAS  Article  Google Scholar 

  4. 4.

    Radhakrishnan K et al (1993) Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol 50(1):78–80

    CAS  Article  Google Scholar 

  5. 5.

    Radhakrishnan K et al (1993) Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci 116(1):18–28

    CAS  Article  Google Scholar 

  6. 6.

    Kesler A et al (2014) The incidence of idiopathic intracranial hypertension in Israel from 2005 to 2007: results of a nationwide survey. Eur J Neurol 21(8):1055–1059

    CAS  Article  Google Scholar 

  7. 7.

    Asensio-Sanchez VM et al (2007) Epidemiology of Pseudotumor Cerebri. Arch Soc Esp Oftalmol 82:219–222

    CAS  PubMed  Google Scholar 

  8. 8.

    Almarzouqi SJ, Morgan ML, Lee AG (2015) Idiopathic intracranial hypertension in the Middle East: a growing concern. Saudi J Ophthalmol 29(1):26–31

    Article  Google Scholar 

  9. 9.

    Friesner D et al (2011) Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs. Obes Rev 12(5):e372–e380

    CAS  Article  Google Scholar 

  10. 10.

    Yri HM et al (2014) The course of headache in idiopathic intracranial hypertension: a 12-month prospective follow-up study. Eur J Neurol 21(12):1458–1464

    CAS  Article  Google Scholar 

  11. 11.

    Yri HM, Jensen RH (2015) Idiopathic intracranial hypertension: clinical nosography and field-testing of the ICHD diagnostic criteria. A case-control study. Cephalalgia 35(7):553–562

    Article  Google Scholar 

  12. 12.

    Wall M et al (2014) The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 71(6):693–701

    Article  Google Scholar 

  13. 13.

    Markey KA et al (2016) Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. The Lancet Neurology 15(1):78–91

    Article  Google Scholar 

  14. 14.

    Hoffmann J, Goadsby PJ (2013) Update on intracranial hypertension and hypotension. Curr Opin Neurol 26(3):240–247

    Article  Google Scholar 

  15. 15.

    Hoffmann J (2015) Headache Attributed to Intracranial Hypertension and Hypotension. In: Mitsikostas DD, Pameleire K (eds) Pharmacological Management of Headaches. Springer, pp 189–205

  16. 16.

    Hoffmann J, May A (2017) Update on Pseudotumor Cerebri (idiopathic intracranial hypertension). Neurology International Open 01(03):E224–E231

    Article  Google Scholar 

  17. 17.

    Hoffmann J (2017) Impaired cerebrospinal fluid pressure. In: Deisenhammer F, Teunissen CE, Tumani H (eds) Cerebrospinal Fluid in Neurological Disorders. Elsevier B.V., San Diego, pp 171–186

    Google Scholar 

  18. 18.

    Hoffmann J et al (2018) European headache federation guideline on idiopathic intracranial hypertension. J Headache Pain 19(1):93

    Article  Google Scholar 

  19. 19.

    Friedman DI et al (2017) Headache in idiopathic intracranial hypertension: findings from the idiopathic intracranial hypertension treatment trial. Headache 57(8):1195–1205

    Article  Google Scholar 

  20. 20.

    McCammon A, Kaufman HH, DSears ES (1981) Transient oculomotor paralysis in pseudotumor cerebri. Neurology 31(2):182–184

    CAS  Article  Google Scholar 

  21. 21.

    Lee AG (1995) Fourth nerve palsy in pseudotumor cerebri. Strabismus 3(2):57–59

    CAS  Article  Google Scholar 

  22. 22.

    Davenport RJ, Will RG, Galloway PJ (1994) Isolated intracranial hypertension presenting with trigeminal neuropathy. J Neurol Neurosurg Psychiatry 57(3):381

    CAS  Article  Google Scholar 

  23. 23.

    Capobianco DJ, Brazis PW, Cheshire WP (1997) Idiopathic intracranial hypertension and seventh nerve palsy. Headache 37(5):286–288

    CAS  Article  Google Scholar 

  24. 24.

    Soroken C, Lacroix L, Korff CM (2016) Combined VIth and VIIth nerve palsy: consider idiopathic intracranial hypertension! Eur J Paediatr Neurol 20(2):336–338

    Article  Google Scholar 

  25. 25.

    Schmidt C et al (2012) Structural olfactory nerve changes in patients suffering from idiopathic intracranial hypertension. PLoS One 7(4):e35221

    CAS  Article  Google Scholar 

  26. 26.

    Kunte H et al (2013) Olfactory dysfunction in patients with idiopathic intracranial hypertension. Neurology 81(4):379–382

    CAS  Article  Google Scholar 

  27. 27.

    Khoo KF, Kunte H (2014) Olfactory dysfunction in patients with idiopathic intracranial hypertension. Neurology 82(2):189

    Article  Google Scholar 

  28. 28.

    Becker N et al (2016) Rapid improvement of olfaction after lumbar puncture in a patient with idiopathic intracranial hypertension. Headache 56:890–892

    Article  Google Scholar 

  29. 29.

    Sorensen PS, Thomsen AM, Gjerris F (1986) Persistent disturbances of cognitive functions in patients with pseudotumor cerebri. Acta Neurol Scand 73(3):264–268

    CAS  Article  Google Scholar 

  30. 30.

    Yri HM et al (2014) Cognitive function in idiopathic intracranial hypertension: a prospective case–control study. BMJ Open 4(4):e004376

    Article  Google Scholar 

  31. 31.

    Kaplan CP, Miner ME, McGregor JM (1997) Pseudotumour cerebri: risk for cognitive impairment? Brain Inj 11(4):293–303

    CAS  Article  Google Scholar 

  32. 32.

    Kharkar S et al (2011) Cognitive impairment in patients with Pseudotumor Cerebri syndrome. Behav Neurol 24(2):143–148

    Article  Google Scholar 

  33. 33.

    Wall M, George D (1991) Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 114(Pt 1A):155–180

    PubMed  Google Scholar 

  34. 34.

    Keltner JL et al (2014) Baseline visual field findings in the idiopathic intracranial hypertension treatment trial (IIHTT). Invest Ophthalmol Vis Sci 55(5):3200–3207

    Article  Google Scholar 

  35. 35.

    Mollan SP et al (2018) Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry; 89(10):1088-1100

  36. 36.

    Schmidt C et al (2017) Does IIH Alter brain microstructures? – a DTI-based approach. Headache. EPub ahead of print

  37. 37.

    Hayreh SS (2016) Pathogenesis of optic disc edema in raised intracranial pressure. Prog Retin Eye Res 50:108–144

    Article  Google Scholar 

  38. 38.

    Walsh FB, Hedges TR (1950) Optic nerve sheath hemorrhage. Trans Am Acad Ophthalmol Otolaryngol 55:29–48

    CAS  PubMed  Google Scholar 

  39. 39.

    Hoffmann J et al (2014) Volumetric assessment of optic nerve sheath and hypophysis in idiopathic intracranial hypertension. AJNR Am J Neuroradiol 35(3):513–518

    CAS  Article  Google Scholar 

  40. 40.

    Hoffmann J et al (2013) Morphometric and volumetric MRI changes in idiopathic intracranial hypertension. Cephalalgia 33(13):1075–1084

    Article  Google Scholar 

  41. 41.

    Digre KB et al (2009) A comparison of idiopathic intracranial hypertension with and without papilledema. Headache 49(2):185–193

    Article  Google Scholar 

  42. 42.

    Yri H et al (2012) Idiopathic intracranial hypertension is not benign: a long-term outcome study. J Neurol 259(5):886–894

    Article  Google Scholar 

  43. 43.

    Hui ES et al (2007) Diffusion tensor MR study of optic nerve degeneration in glaucoma. Conf Proc IEEE Eng Med Biol Soc 2007:4312–4315

    PubMed  Google Scholar 

  44. 44.

    Schoth F et al (2006) Diffusion tensor imaging in acquired blind humans. Neurosci Lett 398(3):178–182

    CAS  Article  Google Scholar 

  45. 45.

    Salmela MB et al (2010) Magnetic resonance diffusion tensor imaging (MRDTI) and tractography in children with septo-optic dysplasia. Pediatr Radiol 40(5):708–713

    Article  Google Scholar 

  46. 46.

    Headache Classification Committee of the International Headache Society (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33(9):629–808

    Article  Google Scholar 

  47. 47.

    Veraart J et al (2016) Denoising of diffusion MRI using random matrix theory. Neuroimage 142:394–406

    Article  Google Scholar 

  48. 48.

    Smith SM et al (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(Suppl 1):S208–S219

    Article  Google Scholar 

  49. 49.

    Tustison NJ et al (2010) N4ITK: improved N3 bias correction. IEEE Trans Med Imaging 29(6):1310–1320

    Article  Google Scholar 

  50. 50.

    Tournier J-D, Calamante F, Connelly A (2010) Improved probabilistic streamlines tractography by 2nd order integration over fibre orientation distributions. In: Proceedings of the International Society for Magnetic Resonance in Medicine, 2010, 1670. International Society for Magnetic Resonance in Medicine

  51. 51.

    Woolrich MW et al (2009) Bayesian analysis of neuroimaging data in FSL. Neuroimage 45(1 Suppl):S173–S186

    Article  Google Scholar 

  52. 52.

    Jenkinson M et al (2012) FSL. Neuroimage 62(2):782–790

    Article  Google Scholar 

  53. 53.

    Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17(3):143–155

    Article  Google Scholar 

  54. 54.

    Smith SM et al (2006) Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage 31(4):1487–1505

    Article  Google Scholar 

  55. 55.

    Rueckert D et al (1999) Nonrigid registration using free-form deformations: application to breast MR images. IEEE Trans Med Imaging 18(8):712–721

    CAS  Article  Google Scholar 

  56. 56.

    El-Rafei A et al (2013) Glaucoma classification based on visual pathway analysis using diffusion tensor imaging. Magn Reson Imaging 31(7):1081–1091

    Article  Google Scholar 

  57. 57.

    Lee SW et al (2009) Idiopathic intracranial hypertension; immediate resolution of venous sinus “obstruction” after reducing cerebrospinal fluid pressure to<10cmH(2) O. J Clin Neurosci 16(12):1690–1692

    Article  Google Scholar 

  58. 58.

    Scoffings DJ, Pickard JD, Higgins JN (2007) Resolution of transverse sinus stenoses immediately after CSF withdrawal in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 78(8):911–912

    Article  Google Scholar 

  59. 59.

    Tso MM, Hayreh S (1977) Optic disc edema in raised intracranial pressure: iv. Axoplasmic transport in experimental papilledema. Arch Ophthalmol 95(8):1458–1462

    CAS  Article  Google Scholar 

  60. 60.

    Tso MM, Hayreh S (1977) Optic disc edema in raised intracranial pressure: iii. A pathologic study of experimental papilledema. Arch Ophthalmol 95(8):1448–1457

    CAS  Article  Google Scholar 

  61. 61.

    Patterson DF et al (2018) Comparison of ocular ultrasonography and magnetic resonance imaging for detection of increased intracranial pressure. Front Neurol 9:278

    Article  Google Scholar 

  62. 62.

    Wall M et al (2014) Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA 311(16):1641–1651

    Article  Google Scholar 

  63. 63.

    Lanfermann H et al (2015) Pharmacological MRI (phMRI) of the human central nervous system. Clin Neuroradiol 25(2):259–266

    Article  Google Scholar 

  64. 64.

    Qin Y-Y et al (2013) In vivo quantitative whole-brain diffusion tensor imaging analysis of APP/PS1 transgenic mice using voxel-based and atlas-based methods. Neuroradiology 55(8):1027–1038

    Article  Google Scholar 

  65. 65.

    Yiangou A et al (2019) Therapeutic lumbar puncture for headache in idiopathic intracranial hypertension: minimal gain, is it worth the pain? Cephalalgia 39(2):245–253

    Article  Google Scholar 

Download references


We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charité - Universitätsmedizin Berlin. Fiber tracking was performed using the MRtrix3 package (J-D Tournier, Brain Research Institute, Melbourne, Australia,


not applicable.

Availability of data and materials

The datasets used and/or analyzed during this study are available from the corresponding author upon reasonable request. This does not apply to data or material that could be traced to specific patients as these data are protected by privacy laws.

Author information




JH conceptualized and designed the study, acquired, analyzed and interpreted the data, drafted the manuscript, revised it for its intellectual content and provided the final approval of the completed manuscript. KMK conceptualized and designed the study, acquired, analyzed and interpreted the data, drafted the manuscript, revised it for its intellectual content and provided the final approval of the completed manuscript. CC-S conceptualized and designed the study, analyzed the data and revised it for its intellectual content and provided the final approval of the completed manuscript. NB acquired and analyzed the data. He revised the manuscript for its intellectual content and provided the final approval of the completed manuscript. HK acquired and analyzed the data. He revised the manuscript for its intellectual content and provided the final approval of the completed manuscript. LSF analyzed the data. He revised the manuscript for its intellectual content and provided the final approval of the completed manuscript. AJ analyzed the data. He revised the manuscript for its intellectual content and provided the final approval of the completed manuscript. EW conceptualized and designed the study, acquired, analyzed and interpreted the data, drafted the manuscript, revised it for its intellectual content and provided the final approval of the completed manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Jan Hoffmann or Edzard Wiener.

Ethics declarations

Ethics approval and consent to participate

The study has been approved by the local ethics committee of the Charité - Universitätsmedizin Berlin (EA1/005/15). All patients participating in the study provided written informed consent to participate in the study.

Consent for publication


Competing interests

Jan Hoffmann has consulted for and/or serves on advisory boards for Allergan, Autonomic Technologies Inc. (ATI), Chordate Medical AB, Eli Lilly, Hormosan Pharma, Novartis and Teva. He received honoraria for speaking from Allergan, Autonomic Technologies Inc. (ATI), Chordate Medical AB, Novartis and Teva. These activities are unrelated to the content of this manuscript.

Katharina Maria Kreutz reports no conflict of interest.

Christoph Csapó-Schmidt reports no conflict of interest.

Nils Becker reports no conflict of interest.

Hagen Kunte received personal compensation for speaking from Biogen-Idec, Norvartis, Genzyme, Teva, Merck, Mylan, and Bayer. He also received honoraria for participation in advisory boards from Norvartis, Roche, Genzyme, and Teva as well as travel support to congresses by Norvartis, Genzyme, Teva.

Lucius Samo Fekonja reports no conflict of interest.

Anas Jadan reports no conflict of interest.

Edzard Wiener reports no conflict of interest.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hoffmann, J., Kreutz, K.M., Csapó-Schmidt, C. et al. The effect of CSF drain on the optic nerve in idiopathic intracranial hypertension. J Headache Pain 20, 59 (2019).

Download citation


  • Idiopathic intracranial hypertension
  • MRI
  • DTI
  • Optic nerve
  • Intracranial pressure
  • Lumbar puncture